Powerful lobbying groups are pushing back against a House-passed bill intended to address the growing opioid epidemic. 

The bull market, which is about to become the longest running in recent history, has produced healthy returns for investors. The S&P 500 is up well over 300 percent over the last nine years, but health insurance stocks have logged even more impressive gains.

Several companies that manage prescription drug benefits for insurers say they have not received any commitments from drugmakers to lower list prices. 

When California voters passed a tax on high-income residents in 2004, backers said it would make good on the state’s “failed promise” to help counties pay for the treatment of the mentally ill.

The Trump administration is using new powers to propose a significant decrease in how many opioids drug companies can manufacture in the U.S. in 2019. 

Nevada is looking to save more than $18 million by transitioning the state’s health insurance exchange from healthcare.gov to its own platform under a newly approved contract.